| | | (3E,5E,7E,9E,11E)-Tetradecaaza-1,3,5,7,9,11,13-heptaene 2-fluoroisonicotinate-3,5,6-D3
Formula: C6 D3 H F N O2
TRC-T716580-250MG
T716580
[2H]c1nc(F)c([2H])c(C(=O)O)c1[2H] (3E,5E,7E,9E,11E)-Tetradecaaza-1,3,5,7,9,11,13-heptaene 2-fluoroisonicotinate-3,5,6-DGéâ
Formula: C6 D3 H F N O2
TRC-T716580-250MG
144.118
[2H]c1nc(F)c([2H])c(C(=O)O)c1[2H] (3R,3'R,4S,4'S,5S,5'S,6R,6'R)-2,2'-(5-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methyl-1,3-phenylene)bis(6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol)
Formula: C32 H39 F O12 S
TRC-F953250-100MG
666.708
COC1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)c2cc(Cc3ccc(s3)c4ccc(F)cc4)c(C)c(c2)C5(OC)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O (3R,3'R,4S,4'S,5S,5'S,6R,6'R)-2,2'-(5-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methyl-1,3-phenylene)bis(6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol)
Formula: C32 H39 F O12 S
TRC-F953250-100MG
F953250
COC1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)c2cc(Cc3ccc(s3)c4ccc(F)cc4)c(C)c(c2)C5(OC)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O (3R,3A'R,5S,7A'R)-1'-((2R,5S,E)-5-CYCLOPROPYL-5-HYDROXYPENT-3-EN-2-YL)-7A'-METHYL-1',2,2',3,3',3A',4,5,5',6,6A,6',7',7A'-TETRADECAHYDRO-1AH-SPIRO[CYCLOPROPA[A]INDENE-1,4'-INDENE]-3,5-DIOL
Formula: C27 H40 O3
TRC-C988335-2.5MG
412.605
C[C@H](\C=C\[C@@H](O)C1CC1)C2CC[C@@H]3[C@]2(C)CCCC34C5CC6=C(C[C@@H](O)C[C@@H]6O)C45 (3R,3A'R,5S,7A'R)-1'-((2R,5S,E)-5-CYCLOPROPYL-5-HYDROXYPENT-3-EN-2-YL)-7A'-METHYL-1',2,2',3,3',3A',4,5,5',6,6A,6',7',7A'-TETRADECAHYDRO-1AH-SPIRO[CYCLOPROPA[A]INDENE-1,4'-INDENE]-3,5-DIOL
Formula: C27 H40 O3
TRC-C988335-2.5MG
C988335
C[C@H](\C=C\[C@@H](O)C1CC1)C2CC[C@@H]3[C@]2(C)CCCC34C5CC6=C(C[C@@H](O)C[C@@H]6O)C45 (3R,4S,5S,6R)-6-((((2S,3R,4S,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2-YL)OXY)METHYL)-3,4,5-TRIHYDROXYTETRAHYDRO-2H-PYRAN-2-ONE
Formula: C27 H33 Cl O12
TRC-C381050-25MG
C381050
CCOc1ccc(Cc2cc(ccc2Cl)[C@]3(OC[C@H]4OC(=O)[C@H](O)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc1 (3R,4S,5S,6R)-6-((((2S,3R,4S,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2-YL)OXY)METHYL)-3,4,5-TRIHYDROXYTETRAHYDRO-2H-PYRAN-2-ONE
Formula: C27 H33 Cl O12
TRC-C381050-25MG
584.997
CCOc1ccc(Cc2cc(ccc2Cl)[C@]3(OC[C@H]4OC(=O)[C@H](O)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc1 (3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-Dimethyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic Acid Sodium Salt (Lovastatin Hydroxy Acid Sodium Salt)
CAS:75225-50-2
Formula: C24 H37 O6 . Na
MM0050.01
444.54
[Na+].CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@@H]12 (3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-Dimethyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic Acid Sodium Salt (Lovastatin Hydroxy Acid Sodium Salt)
CAS:75225-50-2
Formula: C24 H37 O6 . Na
MM0050.01
MM0050.01
[Na+].CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@@H]12 (3R,5R)-7-[(1S,2S,6R,8S,8AR)-8-[(2,2-DIMETHYLBUTANOYL)OXY]-2,6-DIMETHYL-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID AMMONIUM SALT (TENIVASTATIN AMMONIUM SALT)
CAS:139893-43-9
Formula: C25 H39 O6 . H4 N
MM0158.13-0025
MM0158.13-0025
[NH4+].CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@@H]12 (3R,5R)-7-[(1S,2S,6R,8S,8AR)-8-[(2,2-DIMETHYLBUTANOYL)OXY]-2,6-DIMETHYL-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID AMMONIUM SALT (TENIVASTATIN AMMONIUM SALT)
CAS:139893-43-9
Formula: C25 H39 O6 . H4 N
MM0158.13
MM0158.13
[NH4+].CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@@H]12 (3R,5R)-7-[(1S,2S,6R,8S,8AR)-8-[(2,2-DIMETHYLBUTANOYL)OXY]-2,6-DIMETHYL-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID AMMONIUM SALT (TENIVASTATIN AMMONIUM SALT)
CAS:139893-43-9
Formula: C25 H39 O6 . H4 N
MM0158.13
453.61
[NH4+].CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@@H]12 (3R,5R)-7-[(1S,2S,6R,8S,8AR)-8-[(2,2-DIMETHYLBUTANOYL)OXY]-2,6-DIMETHYL-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID AMMONIUM SALT (TENIVASTATIN AMMONIUM SALT)
CAS:139893-43-9
Formula: C25 H39 O6 . H4 N
MM0158.13-0025
453.61
[NH4+].CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@@H]12 (3R,5R)-7-[(1S,2S,6R,8S,8AR)-8-[(2,2-DIMETHYLBUTANOYL)OXY]-2,6-DIMETHYL-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID SODIUM SALT
CAS:101314-97-0
Formula: C25 H39 O6 . Na
MM0158.01
458.56
[Na+].CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@@H]12 (3R,5R)-7-[(1S,2S,6R,8S,8AR)-8-[(2,2-DIMETHYLBUTANOYL)OXY]-2,6-DIMETHYL-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID SODIUM SALT
CAS:101314-97-0
Formula: C25 H39 O6 . Na
MM0158.01
MM0158.01
[Na+].CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@@H]12 (3R,5R,6E,8R,9R,11R,13S,14E,16E,18E,20S,22S,25R,33AS)-DEHEXADECAHYDRO TETRADECAHYDRO SIROLIMUS
Formula: C50 H77 N O13
TRC-S745120-100mg
900.145
CO[C@@H]1C[C@H](C[C@@H](C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C4(O)O[C@@H](CC[C@@H](C)C4=O)C[C@H](OC)\C(=C\C=C\C=C\[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)\C(=C\[C@@H](C)C2=O)\C)\C)CC[C@H]1O (3R,5R,6E,8R,9R,11R,13S,14E,16E,18E,20S,22S,25R,33AS)-DEHEXADECAHYDRO TETRADECAHYDRO SIROLIMUS
Formula: C50 H77 N O13
TRC-S745120-100mg
S745120
CO[C@@H]1C[C@H](C[C@@H](C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C4(O)O[C@@H](CC[C@@H](C)C4=O)C[C@H](OC)\C(=C\C=C\C=C\[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)\C(=C\[C@@H](C)C2=O)\C)\C)CC[C@H]1O (3R,5S,8R,9S,10R,13S,14S)-3-((TERT-BUTYLDIMETHYLSILYL)OXY)-10,13-DIMETHYL-5,6,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-17(4H)-ONE
Formula: C25 H42 O2 Si
TRC-B182660-50MG
B182660
CC(C)(C)[Si](C)(C)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]3[C@@]2(C)C=C1 (3R,5S,8R,9S,10R,13S,14S)-3-((TERT-BUTYLDIMETHYLSILYL)OXY)-10,13-DIMETHYL-5,6,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-17(4H)-ONE
Formula: C25 H42 O2 Si
TRC-B182660-50MG
402.685
CC(C)(C)[Si](C)(C)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]3[C@@]2(C)C=C1 (3R,5S,E)-7-(4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-(N-METHYLMETHYLSULFONAMIDO)PYRIMIDIN-5-YL)-3,5-DIHYDROXY-N-METHYL-N-((2S,3R,4R,5R)-2,3,4,5,6-PENTAHYDROXYHEXYL)HEPT-6-ENAMIDE
CAS:2193053-71-1
Formula: C29 H43 F N4 O10 S
TRC-F599070-100mg
658.736
CC(C)c1nc(nc(c1\C=C\[C@@H](O)C[C@@H](O)CC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)c2ccc(F)cc2)N(C)S(=O)(=O)C (3R,5S,E)-7-(4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-(N-METHYLMETHYLSULFONAMIDO)PYRIMIDIN-5-YL)-3,5-DIHYDROXY-N-METHYL-N-((2S,3R,4R,5R)-2,3,4,5,6-PENTAHYDROXYHEXYL)HEPT-6-ENAMIDE
CAS:2193053-71-1
Formula: C29 H43 F N4 O10 S
TRC-F599070-100mg
F599070
CC(C)c1nc(nc(c1\C=C\[C@@H](O)C[C@@H](O)CC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)c2ccc(F)cc2)N(C)S(=O)(=O)C (3R,6E,10E,14E,18E)-2,6,10,15,19,23-HEXAMETHYL-6,10,14,18,22-TETRACOSAPENTAENE-2,3-DIOL
CAS:63976-65-8
Formula: C30 H52 O2
TRC-H293625-25mg
444.733
CC(=CCC\C(=C\CC\C(=C\CC\C=C(/C)\CC\C=C(/C)\CC[C@@H](O)C(C)(C)O)\C)\C)C (3R,6E,10E,14E,18E)-2,6,10,15,19,23-HEXAMETHYL-6,10,14,18,22-TETRACOSAPENTAENE-2,3-DIOL
CAS:63976-65-8
Formula: C30 H52 O2
TRC-H293625-25mg
H293625
CC(=CCC\C(=C\CC\C(=C\CC\C=C(/C)\CC\C=C(/C)\CC[C@@H](O)C(C)(C)O)\C)\C)C |
